메뉴 건너뛰기




Volumn 144, Issue 10, 2006, Pages 705-714

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; VIRUS RNA;

EID: 33646852746     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-144-10-200605160-00004     Document Type: Article
Times cited : (1787)

References (30)
  • 2
    • 0037180344 scopus 로고    scopus 로고
    • Inaugural article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades
    • Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, et al. Inaugural article: a comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A. 2002;99:15584-9.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 15584-15589
    • Tanaka, Y.1    Hanada, K.2    Mizokami, M.3    Yeo, A.E.4    Shih, J.W.5    Gojobori, T.6
  • 3
    • 0033998786 scopus 로고    scopus 로고
    • The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
    • Armstrong GL, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology. 2000;31:777-82.
    • (2000) Hepatology , vol.31 , pp. 777-782
    • Armstrong, G.L.1    Alter, M.J.2    McQuillan, G.M.3    Margolis, H.S.4
  • 4
    • 0037108452 scopus 로고    scopus 로고
    • Empirically calibrated model of hepatitis C virus infection in the United States
    • Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Empirically calibrated model of hepatitis C virus infection in the United States. Am J Epidemiol. 2002;156:761-73.
    • (2002) Am J Epidemiol , vol.156 , pp. 761-773
    • Salomon, J.A.1    Weinstein, M.C.2    Hammitt, J.K.3    Goldie, S.J.4
  • 5
    • 0032538246 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1-39.
    • Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47(RR-19):1-39.
  • 6
    • 34249019922 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention. NHANES 2001-2002 Public Data General Release File Documentation. Accessed at www.cdc.gov/nchs/ data/nhanes/nhanes_01_02/general_data_release_doc.pdf on 1 July 2004.
    • Centers for Disease Control and Prevention. NHANES 2001-2002 Public Data General Release File Documentation. Accessed at www.cdc.gov/nchs/ data/nhanes/nhanes_01_02/general_data_release_doc.pdf on 1 July 2004.
  • 7
    • 34248999179 scopus 로고    scopus 로고
    • General Information about NHANES Interview Data. Accessed at on 1 July
    • Centers for Disease Control and Prevention. General Information about NHANES Interview Data. Accessed at www.cdc.gov/nchs/data/nhanes/ nhanes_01_02/questdoc_b.pdf on 1 July 2004.
    • (2004)
  • 8
    • 34249005623 scopus 로고    scopus 로고
    • NHANES Analytic Guidelines. Accessed at on 1 July
    • Centers for Disease Control and Prevention. NHANES Analytic Guidelines. Accessed at www.cdc.gov/nchs/data/nhanes/ nhanes_general_guidelines_june_04.pdf on 1 July 2004.
    • (2004)
  • 9
    • 0037462736 scopus 로고    scopus 로고
    • Weinbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003;52(RR-1):1-36.
    • Weinbaum C, Lyerla R, Margolis HS. Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003;52(RR-1):1-36.
  • 11
    • 0033799722 scopus 로고    scopus 로고
    • Estimating future hepatitis C morbidity, mortality, and costs in the United States
    • Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health. 2000;90:1562-9.
    • (2000) Am J Public Health , vol.90 , pp. 1562-1569
    • Wong, J.B.1    McQuillan, G.M.2    McHutchison, J.G.3    Poynard, T.4
  • 12
    • 0037387851 scopus 로고    scopus 로고
    • Projecting future complications of chronic hepatitis C in the United States
    • Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003;9:331-8.
    • (2003) Liver Transpl , vol.9 , pp. 331-338
    • Davis, G.L.1    Albright, J.E.2    Cook, S.F.3    Rosenberg, D.M.4
  • 13
    • 0034294827 scopus 로고    scopus 로고
    • Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis
    • Alter HJ, Houghton M. Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis. Nat Med. 2000;6:1082-6.
    • (2000) Nat Med , vol.6 , pp. 1082-1086
    • Alter, H.J.1    Houghton, M.2
  • 15
    • 34247119377 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention, Number 58. Accessed at on 1 July
    • Centers for Disease Control and Prevention. Hepatitis Surveillance Report Number 58. Accessed at www.cdc.gov/ncidod/diseases/hepatitis/biblio/ CDC_2003_Surveill58.pdf on 1 July 2004.
    • (2004) Hepatitis Surveillance Report
  • 16
    • 0025107484 scopus 로고
    • Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection
    • Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA. 1990;264:2231-5.
    • (1990) JAMA , vol.264 , pp. 2231-2235
    • Alter, M.J.1    Hadler, S.C.2    Judson, F.N.3    Mares, A.4    Alexander, W.J.5    Hu, P.Y.6
  • 17
    • 34249053911 scopus 로고    scopus 로고
    • Trends in self-reported injection drug use (IDU) in the United States
    • Boston: Infectious Diseases Society of America;, Abstract no. 860
    • Armstrong GL. Trends in self-reported injection drug use (IDU) in the United States. In: Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America. Boston: Infectious Diseases Society of America; 2004:191. Abstract no. 860.
    • (2004) Proceedings of the 42nd Annual Meeting of the Infectious Diseases Society of America , pp. 191
    • Armstrong, G.L.1
  • 18
    • 0030634075 scopus 로고    scopus 로고
    • The recanting of earlier reported drug use by young adults
    • Johnston LD, O'Malley PM. The recanting of earlier reported drug use by young adults. NIDA Res Monogr. 1997;167:59-80.
    • (1997) NIDA Res Monogr , vol.167 , pp. 59-80
    • Johnston, L.D.1    O'Malley, P.M.2
  • 19
    • 15844389654 scopus 로고    scopus 로고
    • Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection
    • Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med. 1996;334:1691-6.
    • (1996) N Engl J Med , vol.334 , pp. 1691-1696
    • Conry-Cantilena, C.1    VanRaden, M.2    Gibble, J.3    Melpolder, J.4    Shakil, A.O.5    Viladomiu, L.6
  • 20
    • 17544375330 scopus 로고    scopus 로고
    • Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS)
    • Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology. 2000;31:756-62.
    • (2000) Hepatology , vol.31 , pp. 756-762
    • Murphy, E.L.1    Bryzman, S.M.2    Glynn, S.A.3    Ameti, D.I.4    Thomson, R.A.5    Williams, A.E.6
  • 21
    • 1242277288 scopus 로고    scopus 로고
    • Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV
    • Orton SL, Stramer SL, Dodd RY, Alter MJ. Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV. Transfusion. 2004;44:275-81.
    • (2004) Transfusion , vol.44 , pp. 275-281
    • Orton, S.L.1    Stramer, S.L.2    Dodd, R.Y.3    Alter, M.J.4
  • 22
    • 0033993870 scopus 로고    scopus 로고
    • Hepatitis C epidemiology: Injecting new tools in the field [Editorial]
    • Thomas DL. Hepatitis C epidemiology: injecting new tools in the field [Editorial]. Hepatology. 2000;31:790-1.
    • (2000) Hepatology , vol.31 , pp. 790-791
    • Thomas, D.L.1
  • 23
    • 0036532253 scopus 로고    scopus 로고
    • Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment
    • Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155:645-53.
    • (2002) Am J Epidemiol , vol.155 , pp. 645-653
    • Thorpe, L.E.1    Ouellet, L.J.2    Hershow, R.3    Bailey, S.L.4    Williams, I.T.5    Williamson, J.6
  • 24
    • 0036890620 scopus 로고    scopus 로고
    • Hepatitis C virus seroconversion among young injection drug users: Relationships and risks
    • Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002;186:1558-64.
    • (2002) J Infect Dis , vol.186 , pp. 1558-1564
    • Hahn, J.A.1    Page-Shafer, K.2    Lum, P.J.3    Bourgois, P.4    Stein, E.5    Evans, J.L.6
  • 25
    • 0037372517 scopus 로고    scopus 로고
    • Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City
    • Des Jarlais DC, Diaz T, Perlis T, Vlahov D, Maslow C, Latka M, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003;157:467-71.
    • (2003) Am J Epidemiol , vol.157 , pp. 467-471
    • Des Jarlais, D.C.1    Diaz, T.2    Perlis, T.3    Vlahov, D.4    Maslow, C.5    Latka, M.6
  • 26
    • 2442619093 scopus 로고    scopus 로고
    • Hepatitis C incidence - a comparison between injection and noninjection drug users in New York City
    • Fuller CM, Ompad DC, Galea S, Wu Y, Koblin B, Vlahov D. Hepatitis C incidence - a comparison between injection and noninjection drug users in New York City. J Urban Health. 2004;81:20-4.
    • (2004) J Urban Health , vol.81 , pp. 20-24
    • Fuller, C.M.1    Ompad, D.C.2    Galea, S.3    Wu, Y.4    Koblin, B.5    Vlahov, D.6
  • 27
    • 15744362746 scopus 로고    scopus 로고
    • Hepatitis C virus infection among injection drug users: Survival analysis of time to seroconversion
    • Hagan H, Thiede H, Des Jarlais DC. Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology. 2004;15:543-9.
    • (2004) Epidemiology , vol.15 , pp. 543-549
    • Hagan, H.1    Thiede, H.2    Des Jarlais, D.C.3
  • 28
    • 0642303165 scopus 로고    scopus 로고
    • The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update
    • El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817-23.
    • (2003) Ann Intern Med , vol.139 , pp. 817-823
    • El-Serag, H.B.1    Davila, J.A.2    Petersen, N.J.3    McGlynn, K.A.4
  • 29
  • 30


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.